Integrating genomic based information into clinical warfarin (Coumadin) management: an illustrative case report.

Abstract excerpt

Warfarin is a well established oral anticoagulant for the treatment of thromboembolic disorders. Warfarin therapy is complicated by a narrow therapeutic index and marked inter-individual dose variability with therapeutic doses ranging from 1 mg to 10 mg/day. Recently genetic variation and resultant drug metabolizing polymorphisms have been found to contribute to warfarin dose variability with resultant...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anticoagulants
• Share to Cerebral Hemorrhage